Filter
1162
Filtered Results: 1162
Text search:
rifampicin
Featured
Recommendations
135
New Publications
301
Language
Document type
No document type
751
Guidelines
170
Studies & Reports
98
Manuals
62
Strategic & Response Plan
29
Training Material
20
Fact sheets
20
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
62
Western and Central Europe
60
Eastern Europe
36
Nepal
27
South Africa
27
Latin America and the Carribbean
22
Kenya
21
Argentina
19
Colombia
16
Tanzania
16
Nigeria
15
Peru
15
Global
14
Paraguay
14
Uganda
14
Namibia
14
Ethiopia
14
Germany
13
Bangladesh
13
Zambia
13
Indonesia
13
Rwanda
12
Malawi
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Brazil
10
Cambodia
9
South–East Asia Region
9
Mozambique
8
Asia
8
Congo, Democratic Republic of
8
Cameroon
7
Russia
7
Africa
6
Tajikistan
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Madagascar
4
Lesotho
3
Sierra Leone
3
Haiti
3
Georgia
3
Bhutan
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
464
Clinical Guidelines
148
Women & Child Health
25
Public Health
23
Capacity Building
17
Pharmacy & Technologies
14
Key Resources
6
Toolboxes
TB
534
HIV
106
NTDs
51
AMR
44
Pharmacy
42
Refugee
18
Polio
13
COVID-19
9
Ebola
8
Caregiver
6
Conflict
5
Mental Health
4
Global Health Education
3
Rapid Response
2
Natural Hazards
2
Planetary Health
1
Zika
1
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
Integrated Management of Adolescent and Adult Illness (IMAI)
July 2008
16.7.2021
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decisions about appropriate treatment for specific clinical...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
Policy brief. July 2020
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
